Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 11-20 of 22 (Search time: 0.004 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2007	Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy	Karageorgos, L.; Brooks, D.; Harmatz, P.; Ketteridge, D.; Pollard, A.; Melville, E.; Parkinson-Lawrence, E.; Clements, P.; Hopwood, J.
	2005	Prediction of neuropathology in mucopolysaccharidosis I patients	Fuller, M.; Brooks, D.; Evangelista, M.; Hein, L.; Hopwood, J.; Meikle, P.
	2003	Usefulness of bone marrow transplantation in the Hurler syndrome	Braunlin, E.; Stauffer, N.; Peters, C.; Bass, J.; Berry, J.; Hopwood, J.; Krivit, W.
	2008	Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase	Harmatz, P.; Giugliani, R.; Schwartz, I.; Guffon, N.; Teles, E.; Miranda, C.; Wraith, J.; Beck, M.; Arash, L.; Scarpa, M.; Ketteridge, D.; Hopwood, J.; Plecko, B.; Steiner, R.; Whitley, C.; Kaplan, P.; Yu, Z.; Swiedler, S.; Decker, C.
	2003	Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry	Ramsay, S.; Meikle, P.; Hopwood, J.
	2005	Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfatase	Harmatz, P.; Ketteridge, D.; Giugliani, R.; Guffon, N.; Teles, E.; Miranda, C.; Yu, Z.; Swiedler, S.; Hopwood, J.
	2006	Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples	Dean, C.; Bockmann, M.; Hopwood, J.; Brooks, D.; Meikle, P.
	2005	Laronidase treatment of mucopolysaccharidosis I	Wraith, J.; Hopwood, J.; Fuller, M.; Meikle, P.; Brooks, D.
	2001	Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients	Perkins, K.; Muller, V.; Weber, B.; Hopwood, J.
	2002	Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: Implications for the prediction of disease severity	Whitfield, P.; Nelson, P.; Sharp, P.; Bindloss, C.; Dean, C.; Ravenscroft, E.; Fong, B.; Fietz, M.; Hopwood, J.; Meikle, P.